You have free access to this content
Using Cochrane reviews for oral diseases
Article first published online: 30 MAY 2010
DOI: 10.1111/j.1601-0825.2010.01674.x
© 2010 John Wiley & Sons A/S
Additional Information
How to Cite
Worthington, H., Glenny, A.-M., Mauleffinch, L. F., Daly, F. and Clarkson, J. (2010), Using Cochrane reviews for oral diseases. Oral Diseases, 16: 592–596. doi: 10.1111/j.1601-0825.2010.01674.x
Publication History
- Issue published online: 15 SEP 2010
- Article first published online: 30 MAY 2010
- Received 17 November 2009; accepted 18 November 2009
References
- , , (2005). Recall intervals for oral health in primary care patients. Cochrane Database Syst Rev Issue 2. Art. No.: CD004346. doi: http://dx.doi.org/10.1002/14651858.CD004346.pub2.
- , (1995). Systematic reviews. BMJ Publishing Group: London.
- , , (2000). Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer). Cochrane Database Syst Rev (2):CD000978.
- , , (2007a). Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev Issue 1. Art. No.: CD003807. doi: http://dx.doi.org/10.1002/14651858.CD003807.pub3.
- , , (2007b). Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev Issue 2. Art. No.: CD001973. doi: http://dx.doi.org/10.1002/14651858.CD001973.pub3.
- Clinical Guideline 19 (October 2004). Dental Recall: recall interval between routine dental examinations. National Institute for Clinical Excellence (NICE), Department of Health, London. http://www.nice.org.uk/CG019NICEguideline, ISBN: 1-84257-801-4 NICE Clinical Guideline.
- , , et al (2004). A survey of current practice with regard to oral care for children being treated for cancer. Eur J Cancer 40: 1217–1224.
- , , et al (2006). Mouth care for children and young people with cancer: evidence-based guidelines. UKCCSG: Leicester, UK. Available from http://www.cclg.org.uk.
- , , , (2009). Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database Syst Rev Issue 1. Art. No.: CD006706. doi: http://dx.doi.org/10.1002/14651858.CD006706.pub2.
- , , , , (2009). Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev Issue 4: CD001869.
- (1994). Rationale for systematic reviews. BMJ 309: 597–599.
- , , et al (2007). Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database Syst Rev Issue 4. Art. No.: CD006205. doi: http://dx.doi.org/10.1002/14651858.CD006205.pub2.
- , , , (2002). The epidemiology and treatment of Bell’s palsy in the UK. Eur J Neurol 91: 63–67.
- , , , (2002). Corticosteroids for Bell’s Palsy (idiopathic facial paralysis). Cochrane Database Syst Rev Issue 1: CD001942.
- , (2001). Aciclovir for Bell’s Palsy (idiopathic facial paralysis). Cochrane Database Syst Rev Issue 4: CD001869.
- , , et al (2007). Early treatment with prednisolone or acyclovir in Bell’s Palsy. N Engl J Med 357: 1598–1607.
- The Cochrane Collaboration. The reliable source of evidence in health care. Retrieved 28 October, 2009, from http://www.cochrane.org/.
- , , (2007a). Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev Issue 4. Art. No.: CD000978. DOI: http://dx.doi.org/10.1002/14651858.CD000978.pub3.
- , , (2007b). Interventions for treating oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2007. Issue 2. Art. No.: CD001972. doi: http://dx.doi.org/10.1002/14651858.CD001972.pub3.

1601-0825/asset/olbannerleft.png?v=1&s=f2d0341fba459110074b09d48b6db7ccc0cf5f13)
1601-0825/asset/olbannercenter.png?v=1&s=cdbba4cfc983e214de06fa140cb1ce7c4a6e48ba)
1601-0825/asset/olbannerright.png?v=1&s=737ecc992f844f163013eece71465fa0ae564b2a)
